MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1

Background The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. Aims This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regu...

Full description

Saved in:
Bibliographic Details
Published inIrish journal of medical science Vol. 193; no. 2; pp. 909 - 916
Main Authors Huang, Shuo, Xiao, Xia, Wu, Hongman, Zhou, Feng, Fu, Chenchao
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. Aims This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs). Methods GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis ( n  = 35), simple steatosis ( n  = 35), and NASH ( n  = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR‐582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro. Results miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients’ plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers’ expression but induced cell apoptosis, via TMBIM1. Conclusions This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.
AbstractList The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs). GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro. miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1. This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.
Background The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. Aims This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs). Methods GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis ( n  = 35), simple steatosis ( n  = 35), and NASH ( n  = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR‐582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro. Results miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients’ plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers’ expression but induced cell apoptosis, via TMBIM1. Conclusions This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.
The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.BACKGROUNDThe gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.This study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).AIMSThis study was aimed to investigate the correlation between gut microbiota and miR-582-3p in patients with non-alcoholic steatohepatitis (NASH) and to explore the possible regulation of miR-582-3p in the function of the activated hepatic stellate cells (HSCs).GSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.METHODSGSE69670 and GSE14435 datasets were analyzed by GEO2R. Plasma and fecal samples were obtained from the subjects, non-steatosis (n = 35), simple steatosis (n = 35), and NASH (n = 35). The variations in intestinal microbiota in the non-steatosis and NASH groups were analyzed using 16S rRNA sequencing. The expression of miR-582-3p among the groups was detected using RT-qPCR. Correlations between top-changed intestinal microbiota and miR-582-3p expression were analyzed using the Pearson correlation coefficient. Target gene identification was performed by prediction and dual-luciferase reporter assay. The effect of miR-582-3p on the cell function of TGF-β1-induced HSCs was assessed in vitro.miR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1.RESULTSmiR-582-3p was the common differentially expressed miRNA between GSE69670 and GSE14435. miR-582-3p was upregulated in NASH patients' plasma, as well as in TGF-β1-induced LX-2 cells. The non-steatosis and NASH groups showed significantly different intestinal microbiota distribution. miR-582-3p was positively correlated with specific microbiota populations. TMBIM1 was a target gene for miR-582-3p. Knockdown of miR-582-3p suppressed HSC proliferation and myofibroblast markers' expression but induced cell apoptosis, via TMBIM1.This present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.CONCLUSIONSThis present study suggests that miR-582-3p promotes the progression of NASH. Knockdown of miR-582-3p may alleviate NASH by altering the gut microbiota composition and moderating TMBIM1.
Author Huang, Shuo
Wu, Hongman
Zhou, Feng
Xiao, Xia
Fu, Chenchao
Author_xml – sequence: 1
  givenname: Shuo
  surname: Huang
  fullname: Huang, Shuo
  organization: Department of Internal Medicine, Hunan Maternal and Child Health Hospital
– sequence: 2
  givenname: Xia
  surname: Xiao
  fullname: Xiao, Xia
  organization: Department of Internal Medicine, Hunan Maternal and Child Health Hospital
– sequence: 3
  givenname: Hongman
  surname: Wu
  fullname: Wu, Hongman
  organization: Department of Infection Control Center, Xiangya Hospital of Central South University
– sequence: 4
  givenname: Feng
  surname: Zhou
  fullname: Zhou, Feng
  organization: Department of Infection Control Center, Xiangya Hospital of Central South University
– sequence: 5
  givenname: Chenchao
  surname: Fu
  fullname: Fu, Chenchao
  email: Fuchenchao6112@163.com
  organization: Department of Infection Control Center, Xiangya Hospital of Central South University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37823951$$D View this record in MEDLINE/PubMed
BookMark eNp9kb1OHDEYRa0IFBbIC6SIXKYx8b89JUFJQGKDhLa3PB4Pa5gZT2xPVtR58Xiz0KSgcnPOtb57T8HRFCcPwEeCLwjG6ksmRHOBMGUIM0EbtHsHVkRLhjiT9AisMKYEESrFCTjN-RFj1jDJ34MTpjRljSAr8GcdXIr3Py-R0BSxGT5N0T11cTdBOwz-d7DFZ1g_RnZwcRuH4GAu3pa49bMtoYQM2-fKFp_C9ADL1sOHpcBxH9uGWCx0cZxjrmSsmVMHx9j5VNVKb9Zfb9bkHBz3dsj-w8t7Bjbfv22urtHt3Y-bq8tb5BhXBWnFqabK2h43jVLatRJz2lnFGypEy3rmrHaN7ySXXS8s4ayXnuPeeSYsZWfg8yF2TvHX4nMxY8jOD4OdfFyyoVpJybgWrKKfXtClHX1n5hRGm57Na28V0AegXplz8r1xodj9iSXZMBiCzX4ic5jI1InMv4nMrqr0P_U1_U2JHaQ872v2yTzGJU21rbesv-3tpV4
CitedBy_id crossref_primary_10_3390_onco5010009
crossref_primary_10_3390_ijms25158042
crossref_primary_10_1136_gutjnl_2024_332398
Cites_doi 10.3350/cmh.2022.0237
10.1016/j.tim.2018.10.011
10.1016/j.jnutbio.2017.02.003
10.1007/s11684-018-0645-9
10.1002/hep4.1479
10.1038/nm.4334
10.1111/imm.12390
10.1136/gutjnl-2018-316723
10.1002/hep.26494
10.1056/NEJMoa2029349
10.1016/j.drudis.2022.05.003
10.1097/tp.0000000000002484
10.1111/tra.12488
10.1016/j.addr.2017.05.007
10.1007/s11845-022-02988-x
10.1016/s0140-6736(20)32511-3
10.2147/ceg.S262879
10.1016/j.jhep.2013.12.019
10.1111/febs.12806
10.1007/s11154-019-09512-0
10.1016/j.trsl.2019.07.007
10.1038/s41366-021-00985-1
10.3390/jcm5030038
10.3389/fendo.2020.597648
10.3390/ijms20020395
10.3390/cells9061534
10.1093/advances/nmy078
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Copyright_xml – notice: The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1007/s11845-023-03529-w
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1863-4362
EndPage 916
ExternalDocumentID 37823951
10_1007_s11845_023_03529_w
Genre Journal Article
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
203
28-
29J
29~
2J2
2JN
2JY
2KG
2LR
2VQ
2~H
30V
4.4
406
408
40D
40E
53G
5GY
5VS
67Z
6NX
78A
875
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABMNI
ABMOR
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACUDM
ACZOJ
ADHHG
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADQRH
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEGXH
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFEXP
AFFNX
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHSBF
AHYZX
AIAGR
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
CAG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
H13
HF~
HG5
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KDC
KOV
KPH
LLZTM
M4Y
MA-
MK0
N2Q
NDZJH
NF0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PT4
PT5
QOK
QOR
R4E
R89
R9I
RHV
RNI
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK8
XAX
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ACSTC
ADHKG
AFDZB
AFOHR
AGQPQ
AHPBZ
ATHPR
AYFIA
CITATION
ABRTQ
NPM
7X8
ID FETCH-LOGICAL-c347t-8742827aaf099778cb6042da749255b3f3ca8c9ed646df5a143f6e40fce35a23
IEDL.DBID U2A
ISSN 0021-1265
1863-4362
IngestDate Fri Jul 11 07:03:30 EDT 2025
Mon Jul 21 05:45:27 EDT 2025
Tue Jul 01 02:09:42 EDT 2025
Thu Apr 24 23:12:05 EDT 2025
Fri Feb 21 02:44:48 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Gut microbiota
Hepatic stellate cell
Non-alcoholic steatohepatitis
MicroRNA-582-3p
Language English
License 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c347t-8742827aaf099778cb6042da749255b3f3ca8c9ed646df5a143f6e40fce35a23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 37823951
PQID 2876634853
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2876634853
pubmed_primary_37823951
crossref_citationtrail_10_1007_s11845_023_03529_w
crossref_primary_10_1007_s11845_023_03529_w
springer_journals_10_1007_s11845_023_03529_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20240400
2024-04-00
2024-Apr
20240401
PublicationDateYYYYMMDD 2024-04-01
PublicationDate_xml – month: 4
  year: 2024
  text: 20240400
PublicationDecade 2020
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Ireland
PublicationTitle Irish journal of medical science
PublicationTitleAbbrev Ir J Med Sci
PublicationTitleAlternate Ir J Med Sci
PublicationYear 2024
Publisher Springer International Publishing
Publisher_xml – name: Springer International Publishing
References Younossi, Marchesini, Pinto-Cortez, Petta (CR1) 2019; 103
Longo, Tonin Ferrari, Rampelotto (CR14) 2020; 13
CR19
Mennitti, Carpenter, Loche (CR25) 2005; 46
CR13
Ferreira, Simão, Rodrigues, Castro (CR12) 2014; 281
Lee, Wu, Lin (CR7) 2023; 29
Cani (CR20) 2018; 67
Zhao, Zhang, Gong (CR16) 2017; 23
Sud, Zhang, Pan (CR24) 2017; 43
Khan, Gupta, Mahapatra (CR18) 2022; 27
Han, Ma, Li (CR11) 2018; 12
Zhao, Lin, Cheng (CR15) 2019; 214
Yu, Wang, Lai (CR2) 2023; 192
Schoeler, Caesar (CR17) 2019; 20
Guerrero-Mandujano, Hernández-Cortez, Ibarra, Castro-Escarpulli (CR21) 2017; 18
Bajaj, Heuman, Hylemon (CR10) 2014; 60
CR4
Chassaing, Etienne-Mesmin, Gewirtz (CR9) 2014; 59
Higashi, Friedman, Hoshida (CR26) 2017; 121
Parthasarathy, Revelo, Malhi (CR6) 2020; 4
CR8
Sanyal, Van Natta, Clark (CR5) 2021; 385
CR27
Smyth, Boardman, Tung (CR23) 2015; 144
Aguilar, Mano, Eulalio (CR22) 2019; 27
Powell, Wong, Rinella (CR3) 2021; 397
JS Bajaj (3529_CR10) 2014; 60
N Sud (3529_CR24) 2017; 43
C Aguilar (3529_CR22) 2019; 27
EE Powell (3529_CR3) 2021; 397
ZM Younossi (3529_CR1) 2019; 103
M Schoeler (3529_CR17) 2019; 20
LA Smyth (3529_CR23) 2015; 144
T Higashi (3529_CR26) 2017; 121
B Chassaing (3529_CR9) 2014; 59
3529_CR27
AJ Sanyal (3529_CR5) 2021; 385
L Longo (3529_CR14) 2020; 13
PD Cani (3529_CR20) 2018; 67
X Yu (3529_CR2) 2023; 192
3529_CR4
DM Ferreira (3529_CR12) 2014; 281
R Han (3529_CR11) 2018; 12
3529_CR13
LV Mennitti (3529_CR25) 2005; 46
3529_CR8
AA Khan (3529_CR18) 2022; 27
KC Lee (3529_CR7) 2023; 29
Z Zhao (3529_CR15) 2019; 214
G Parthasarathy (3529_CR6) 2020; 4
GN Zhao (3529_CR16) 2017; 23
3529_CR19
A Guerrero-Mandujano (3529_CR21) 2017; 18
References_xml – volume: 29
  start-page: 77
  year: 2023
  end-page: 98
  ident: CR7
  article-title: Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
  publication-title: Clin Mol Hepatol
  doi: 10.3350/cmh.2022.0237
– volume: 27
  start-page: 206
  year: 2019
  end-page: 218
  ident: CR22
  article-title: MicroRNAs at the host-bacteria interface: host defense or bacterial offense
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2018.10.011
– volume: 43
  start-page: 125
  year: 2017
  end-page: 131
  ident: CR24
  article-title: Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2017.02.003
– ident: CR4
– volume: 12
  start-page: 645
  year: 2018
  end-page: 657
  ident: CR11
  article-title: Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
  publication-title: Front Med
  doi: 10.1007/s11684-018-0645-9
– volume: 4
  start-page: 478
  year: 2020
  end-page: 492
  ident: CR6
  article-title: Pathogenesis of nonalcoholic steatohepatitis: an overview
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1479
– volume: 23
  start-page: 742
  year: 2017
  end-page: 752
  ident: CR16
  article-title: Tmbim1 is a multivesicular body regulator that protects against non-alcoholic fatty liver disease in mice and monkeys by targeting the lysosomal degradation of Tlr4
  publication-title: Nat Med
  doi: 10.1038/nm.4334
– volume: 144
  start-page: 197
  year: 2015
  end-page: 205
  ident: CR23
  article-title: MicroRNAs affect dendritic cell function and phenotype
  publication-title: Immunology
  doi: 10.1111/imm.12390
– volume: 67
  start-page: 1716
  year: 2018
  end-page: 1725
  ident: CR20
  article-title: Human gut microbiome: hopes, threats and promises
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-316723
– ident: CR8
– volume: 59
  start-page: 328
  year: 2014
  end-page: 339
  ident: CR9
  article-title: Microbiota-liver axis in hepatic disease
  publication-title: Hepatology (Baltimore, MD)
  doi: 10.1002/hep.26494
– ident: CR27
– volume: 385
  start-page: 1559
  year: 2021
  end-page: 1569
  ident: CR5
  article-title: Prospective study of outcomes in adults with nonalcoholic fatty liver disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2029349
– ident: CR19
– volume: 27
  start-page: 2170
  year: 2022
  end-page: 2180
  ident: CR18
  article-title: Key regulatory miRNAs in lipid homeostasis: implications for cardiometabolic diseases and development of novel therapeutics
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2022.05.003
– volume: 103
  start-page: 22
  year: 2019
  end-page: 27
  ident: CR1
  article-title: Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation
  publication-title: Transplantation
  doi: 10.1097/tp.0000000000002484
– volume: 18
  start-page: 425
  year: 2017
  end-page: 432
  ident: CR21
  article-title: The outer membrane vesicles: secretion system type zero
  publication-title: Traffic (Copenhagen, Denmark)
  doi: 10.1111/tra.12488
– volume: 121
  start-page: 27
  year: 2017
  end-page: 42
  ident: CR26
  article-title: Hepatic stellate cells as key target in liver fibrosis
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2017.05.007
– volume: 192
  start-page: 131
  year: 2023
  end-page: 142
  ident: CR2
  article-title: Comparative efficacy of exercise training processes in improving nonalcoholic fatty liver disease: a systematic review and meta-analysis
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-022-02988-x
– volume: 397
  start-page: 2212
  year: 2021
  end-page: 2224
  ident: CR3
  article-title: Non-alcoholic fatty liver disease
  publication-title: Lancet (London, England)
  doi: 10.1016/s0140-6736(20)32511-3
– volume: 13
  start-page: 351
  year: 2020
  end-page: 368
  ident: CR14
  article-title: Gut dysbiosis and increased intestinal permeability drive microRNAs, NLRP-3 inflammasome and liver fibrosis in a nutritional model of non-alcoholic steatohepatitis in adult male Sprague Dawley rats
  publication-title: Clin Exp Gastroenterol
  doi: 10.2147/ceg.S262879
– volume: 60
  start-page: 940
  year: 2014
  end-page: 947
  ident: CR10
  article-title: Altered profile of human gut microbiome is associated with cirrhosis and its complications
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2013.12.019
– ident: CR13
– volume: 281
  start-page: 2503
  year: 2014
  end-page: 2524
  ident: CR12
  article-title: Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease
  publication-title: FEBS J
  doi: 10.1111/febs.12806
– volume: 20
  start-page: 461
  year: 2019
  end-page: 472
  ident: CR17
  article-title: Dietary lipids, gut microbiota and lipid metabolism
  publication-title: Rev Endocr Metab Disord
  doi: 10.1007/s11154-019-09512-0
– volume: 214
  start-page: 17
  year: 2019
  end-page: 29
  ident: CR15
  article-title: siRNA- and miRNA-based therapeutics for liver fibrosis
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2019.07.007
– volume: 46
  start-page: 269
  year: 2005
  end-page: 278
  ident: CR25
  article-title: Ozanne SE (2022) Effects of maternal diet-induced obesity on metabolic disorders and age-associated miRNA expression in the liver of male mouse offspring
  publication-title: Int J Obes
  doi: 10.1038/s41366-021-00985-1
– ident: 3529_CR27
  doi: 10.3390/jcm5030038
– ident: 3529_CR4
  doi: 10.3389/fendo.2020.597648
– volume: 144
  start-page: 197
  year: 2015
  ident: 3529_CR23
  publication-title: Immunology
  doi: 10.1111/imm.12390
– volume: 27
  start-page: 2170
  year: 2022
  ident: 3529_CR18
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2022.05.003
– ident: 3529_CR8
  doi: 10.3390/ijms20020395
– volume: 29
  start-page: 77
  year: 2023
  ident: 3529_CR7
  publication-title: Clin Mol Hepatol
  doi: 10.3350/cmh.2022.0237
– volume: 59
  start-page: 328
  year: 2014
  ident: 3529_CR9
  publication-title: Hepatology (Baltimore, MD)
  doi: 10.1002/hep.26494
– volume: 12
  start-page: 645
  year: 2018
  ident: 3529_CR11
  publication-title: Front Med
  doi: 10.1007/s11684-018-0645-9
– ident: 3529_CR19
  doi: 10.3390/cells9061534
– volume: 23
  start-page: 742
  year: 2017
  ident: 3529_CR16
  publication-title: Nat Med
  doi: 10.1038/nm.4334
– volume: 385
  start-page: 1559
  year: 2021
  ident: 3529_CR5
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2029349
– volume: 121
  start-page: 27
  year: 2017
  ident: 3529_CR26
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2017.05.007
– volume: 192
  start-page: 131
  year: 2023
  ident: 3529_CR2
  publication-title: Ir J Med Sci
  doi: 10.1007/s11845-022-02988-x
– volume: 67
  start-page: 1716
  year: 2018
  ident: 3529_CR20
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-316723
– volume: 18
  start-page: 425
  year: 2017
  ident: 3529_CR21
  publication-title: Traffic (Copenhagen, Denmark)
  doi: 10.1111/tra.12488
– ident: 3529_CR13
  doi: 10.1093/advances/nmy078
– volume: 397
  start-page: 2212
  year: 2021
  ident: 3529_CR3
  publication-title: Lancet (London, England)
  doi: 10.1016/s0140-6736(20)32511-3
– volume: 13
  start-page: 351
  year: 2020
  ident: 3529_CR14
  publication-title: Clin Exp Gastroenterol
  doi: 10.2147/ceg.S262879
– volume: 20
  start-page: 461
  year: 2019
  ident: 3529_CR17
  publication-title: Rev Endocr Metab Disord
  doi: 10.1007/s11154-019-09512-0
– volume: 60
  start-page: 940
  year: 2014
  ident: 3529_CR10
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2013.12.019
– volume: 281
  start-page: 2503
  year: 2014
  ident: 3529_CR12
  publication-title: FEBS J
  doi: 10.1111/febs.12806
– volume: 103
  start-page: 22
  year: 2019
  ident: 3529_CR1
  publication-title: Transplantation
  doi: 10.1097/tp.0000000000002484
– volume: 27
  start-page: 206
  year: 2019
  ident: 3529_CR22
  publication-title: Trends Microbiol
  doi: 10.1016/j.tim.2018.10.011
– volume: 46
  start-page: 269
  year: 2005
  ident: 3529_CR25
  publication-title: Int J Obes
  doi: 10.1038/s41366-021-00985-1
– volume: 214
  start-page: 17
  year: 2019
  ident: 3529_CR15
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2019.07.007
– volume: 43
  start-page: 125
  year: 2017
  ident: 3529_CR24
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2017.02.003
– volume: 4
  start-page: 478
  year: 2020
  ident: 3529_CR6
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1479
SSID ssj0039364
Score 2.3344734
Snippet Background The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. Aims This study was aimed to investigate...
The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs. This study was aimed to investigate the correlation...
The gut dysbiosis correlates with non-alcoholic steatohepatitis (NASH), involving the moderation of miRNAs.BACKGROUNDThe gut dysbiosis correlates with...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 909
SubjectTerms Family Medicine
General Practice
Internal Medicine
Medicine
Medicine & Public Health
Original Article
Title MicroRNA-582-3p knockdown alleviates non-alcoholic steatohepatitis by altering the gut microbiota composition and moderating TMBIM1
URI https://link.springer.com/article/10.1007/s11845-023-03529-w
https://www.ncbi.nlm.nih.gov/pubmed/37823951
https://www.proquest.com/docview/2876634853
Volume 193
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9wwEB0VVkJcqrZ8dGmLXIkbWNrEH0mO2wq6bRUOaJHgFDm2AyvagNhsUc_9451JHBDaaqXeHdvKs8dvNDNvAA5U6pSspODClQ4dFG95mvmYizStHNJrNxJUnJyf6sm5_HahLkJR2LzPdu9Dkq2lfip2Q2eEqokFJw3PjD-swUCh706JXOfxuLe_IhM6aC9HPIq1CqUy_57j-XO0xDGX4qPts3PyCl4GvsjGHcCv4YWv38BGHiLiW_Anp4y6s9MxV0hixR27qdHCOfStGXVJ-TUjLsnQx-ema4Y7s4yAbW6vPSVTN7M5K3-zNmiOG2DIB9nVomE_Z51CU2MYZZ2H1C5maseoeQ6dGxw9zT99zaNtmJ4cTz9PeGiswK2QSYMWEJ2OODGmorrZJLWlxrvrTEJKhaoUlbAmtZl3WmpXKYOcqtJejirrhTKx2IF13Ld_C8yMUo8oa-eqTEqfZs7o2JKKvUPuopMhRP3vLWwQHafeFz-KJ7lkgqRASIoWkuJhCIeP39x1khsrR3_sUSvwZlC4w9T-djEv0BdEOiWRjwxht4PzcT6BxEgguRzCUY9vES7vfMVie_83_B1s4vkMiT7vYb25X_gPyGGach8G4y-X34_326P7Fwjq6e0
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1NT9wwEB0VKgEX1JYWFvrhSr21lnZjx3GO26poackeqkXiZjm2AytgF7FZEGf-ODOJA6qokHp3bCvPHr_RzLwB-JJqn8pKCi586dFBCY7rPCRcaF15pNe-L6g4uRir0ZH8dZwex6KwRZft3oUkG0v9WOyGzghVEwtOGp45v1mBl0gGNJ3lo2TY2V-RCxW1lwd8kKg0lsr8e46_n6MnHPNJfLR5dvZfwWbki2zYAvwaXoTZG1grYkR8C-4Kyqj7Mx7yFEmsuGRnM7RwHn1rRl1SrqfEJRn6-Ny2zXCnjhGw9fw0UDJ1PV2w8pY1QXPcAEM-yE6WNbuYtgpNtWWUdR5Tu5ideUbNc-jc4OhJ8f2gGLyFyf7PyY8Rj40VuBMyq9ECotORZNZWVDebaVcqvLveZqRUmJaiEs5qlwevpPJVapFTVSrIfuWCSG0i3sEq7jvsALN9HRBl5X2VSxl07q1KHKnYe-QuKuvBoPu9xkXRcep9cW4e5ZIJEoOQmAYSc9ODrw_fXLaSG8-O_tyhZvBmULjDzsJ8uTDoCyKdkshHerDdwvkwn0BiJJBc9uBbh6-Jl3fxzGK7_zf8E6yPJsWhOTwY_96DjQT5UJv08x5W66tl-IB8pi4_Nsf3Ht3a60w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bT9RAFD5RTIgvBkRlQXBIfNMJu53ptH1cLhtQujFmSXibTOeiG7Rs3C6EZ_645_TCJRgS36ftpN9cvpNzvu8AfIxTF8sgBReucBigeMvTzEdcpGlwSK9dX5A4OR-ro1P55Sw-u6fir6vdu5Rko2kgl6ay2p25sHsnfMPAhJTFgpOfZ8avnsMLSWpgXNGn0bA7i0UmVOvDPOCDSMWtbObf73h4NT3im49ypfUVNFqBVy13ZMMG7FV45svXsJy32fE1uMmpuu77eMhjJLRixs5LPO0cxtmMOqZcTolXMoz3uWka404tI5Cri5-eCqur6ZwV16xOoOMEGHJD9mNRsd_Txq2pMowq0NsyL2ZKx6iRDq0hHD3J947zwRuYjA4n-0e8bbLArZBJhachBiBRYkwgDW2S2kLhPnYmIdfCuBBBWJPazDsllQuxQX4VlJf9YL2ITSTewhLO268DM_3UI-LKuZBJ6dPMGRVZcrR3yGNU0oNB93u1bQ3IqQ_GL31nnUyQaIRE15Doqx58un1m1thvPDl6p0NN4y6h1Icp_cVirjEuRGolkZv04F0D5-37BJIkgUSzB587fHW7kedPfGzj_4Z_gOVvByN9cjz-ugkvI6RGTf3Pe1iq_iz8FlKbqtiuV-9fVLDvfw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MicroRNA-582-3p+knockdown+alleviates+non-alcoholic+steatohepatitis+by+altering+the+gut+microbiota+composition+and+moderating+TMBIM1&rft.jtitle=Irish+journal+of+medical+science&rft.au=Huang%2C+Shuo&rft.au=Xiao%2C+Xia&rft.au=Wu%2C+Hongman&rft.au=Zhou%2C+Feng&rft.date=2024-04-01&rft.eissn=1863-4362&rft.volume=193&rft.issue=2&rft.spage=909&rft_id=info:doi/10.1007%2Fs11845-023-03529-w&rft_id=info%3Apmid%2F37823951&rft.externalDocID=37823951
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-1265&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-1265&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-1265&client=summon